1022880

Acerta Pharma, LLC — FEI 3011684415

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 15, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
South San Francisco, CA (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
748221 CFR 312.50General responsibilities of sponsors